Charles River director James Foster sells $8.4 million in shares

Charles River Laboratories International, Inc. (CRL) saw significant stock activity on October 22, 2026. CEO James C. Foster bought 24,042 shares at $244.41 each, investing $5.88 million. Simultaneously, Foster sold the same number of shares at $350.00 per share, generating $8.41 million. This trade was executed under a pre-approved Rule 10b5-1 plan since March 6, 2026.

Shares were trading close to their 52-week high of $357.77, currently priced at $357.27. Analysts label CRL as overvalued, as per InvestingPro's assessment. In the last six months, CRL shares have climbed over 108%. CRL's upcoming earnings are set for November 4. Following Foster's transactions, he directly owns 31,596 shares. Indirectly, he holds shares via trusts: 5,423 shares through a 2024 GRAT, 10,780 shares through a 2025 GRAT, 20,000 shares via a 2026 GRAT, 10,000 shares held by his spouse, and 155,611 shares in another trust.

Analysts have recently updated their outlook on CRL. UBS gave a buy rating, Jefferies maintained buy and raised price target to $340, TD Cowen increased target to $325, and Mizuho adjusted to $295.